85233-19-8 Usage
Uses
Used in Spectrophotometric Monitoring:
BAPTA is used as a highly selective calcium chelating reagent for the spectrophotometric monitoring of Ca2+ levels. This application allows for the accurate measurement and analysis of calcium ions in various solutions.
Used in Inhibition of Proteolytic Activities:
In the pharmaceutical industry, lipophilic diesters of BAPTA are used for the inhibition of proteolytic activities of certain metalloproteinases, calpain, and TACE. This helps in studying and controlling the activity of these enzymes in various biological processes.
Used in Calcium Chelation:
BAPTA is used as a calcium chelator in various applications, including the measurement of intracellular calcium using 19F labeled forms. This allows researchers to monitor and analyze the levels of calcium ions within cells, which is crucial for understanding various cellular processes and functions.
Biological Activity
Selective calcium chelator.
References
1) Munoz et al. (2015), Different Stress-Induced Calcium Signatures Are Reported by Aequorin-Mediated Calcium Measurements in Living Cells of Aspergillus fumigatus; PLoS One, 10(9) e0138008
2) Wozniak et al. (2017), Extracellular Ca2+ is Required for Fertilization in the African Clawed Frog, Xenopus laevis; PLoS One, 12(1) e0170405
3) Didiasova et al. (2015), STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization; J. Biol. Chem., 290 11983
Check Digit Verification of cas no
The CAS Registry Mumber 85233-19-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,2,3 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 85233-19:
(7*8)+(6*5)+(5*2)+(4*3)+(3*3)+(2*1)+(1*9)=128
128 % 10 = 8
So 85233-19-8 is a valid CAS Registry Number.
85233-19-8Relevant articles and documents
SYNTHESIS OF BAPTA-AM ANALOGUES CAPABLE OF ENHANCING THE VASCULAR PRODUCTION OF PROSTACYCLIN
Heilporn, S.,Broeders, F.,Daloze, D.,Braekman, J. C.,Boeynaems, J. M.
, p. 309 - 320 (2007/10/02)
About 30 analogues of BAPTA-AM, a potential antithrombotic agent, have been synthesized and tested for their effect on the production of prostacyclin.None of them was found to be a better enhancher of the production of prostacyclin by aortic endothelial cells than BAPTA-AM itself.The enhancing effect can be produced by compounds unable to chelate Ca2+, thus confirming that it is not related to their buffering capacity for free Ca2+.